| DB ID | MyCo_1560 |
| Title | Blood Aspergillus RNA is a promising alternative biomarker for invasive aspergillosis |
| Year | 2016 |
| PMID | 27335056 |
| Fungal Diseases involved | Invasive aspergillosis |
| Associated Medical Condition | None |
| Genus | Aspergillus |
| Species | spp. |
| Organism | Aspergillus spp. |
| Ethical Statement | The Institutional Review Board (IRB) or Ethics Commit- tee of each institution as described previously approved the prospective study. Evaluation of Aspergillus RNA biomarker was approved by Rutgers Health Sciences IRB. |
| Site of Infection | None |
| Opportunistic invasive | Invasive |
| Sample type | Body fluid |
| Sample source | Blood |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | BDG |
| Biomarker Full Name | 1-3-beta-D-Glucan |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | USA |
| Cohort | This prospective, noninterventional study conducted at 18 centers across the United States and Belgium has been re- ported recently. a total of 47 patients with proven or probable IA were included in the analysis of correlation between clinical outcome and early changes in serum and BG. |
| Cohort No. | 47 |
| Age Group | None |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | ELISA |
| Analysis Method | ELISA Based |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | ELISA |
| Up Regulation Down Regulation | Positive |
| Sequence Data | None |
| External Link | None |
